Company page

Travere Therapeutics, Inc.

Travere Therapeutics, Inc. (Ticker: TVTX) is a public company based in the United States, focused on developing innovative therapies for rare diseases. With a market capitalization of approximately $5.13 billion, the company is dedicated to addressing unmet medical needs through its advanced research and development efforts. Travere Therapeutics aims to improve the lives of patients by providing effective treatment options for challenging health conditions.